Hunter Perkins Capital Management, LLC Mersana Therapeutics, Inc. Transaction History
Hunter Perkins Capital Management, LLC
- $476 Million
- Q2 2024
A detailed history of Hunter Perkins Capital Management, LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Hunter Perkins Capital Management, LLC holds 10,000 shares of MRSN stock, worth $20,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 15,000
33.33%
Holding current value
$20,200
Previous $67,000
70.15%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding MRSN
# of Institutions
124Shares Held
114MCall Options Held
73.5KPut Options Held
46.4K-
Eco R1 Capital, LLC San Francisco, CA19.4MShares$39.1 Million1.38% of portfolio
-
Vr Adviser, LLC New York, NY11.3MShares$22.9 Million2.5% of portfolio
-
Nextech Invest Ag9.53MShares$19.2 Million3.61% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$17.5 Million3.56% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$16.9 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $196M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...